Editorial: New and emerging lipid-lowering therapies for reducing cardiovascular risk: beyond statins

• Fei Luo,
• Liqing Yu,
• Xunde Xian,
• Bo Shan,
• Avash Das

Affiliations

Fei Luo

Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

Liqing Yu

School of Medicine, University of Maryland, Baltimore, MD, United States

Xunde Xian

Institute of Cardiovascular Sciences and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Peking University, Beijing, China

Bo Shan

Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China

Avash Das

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States